Evidence map›Paper›PMID 40004582›Full record

ArticleJournal of clinical medicine2025

Asymmetric Dimethylarginine (ADMA) as a Novel Risk Factor for Progression of Coronary Artery Calcification in Patients with Chronic Kidney Disease.

Shuzo Kobayashi, Takayasu Ohtake, Yasuhiro Mochida, Kunihiro Ishioka, Machiko Oka, Kyoko Maesato, Hidekazu Moriya, Sumi Hidaka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. A guide to uraemic toxicity.Nature reviews. Nephrology · 2026
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuzo KobayashiDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.
Takayasu OhtakeDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.ORCID 0000-0002-7009-161X
Yasuhiro MochidaDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.
Kunihiro IshiokaDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.ORCID 0000-0001-9129-5075
Machiko OkaDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.
Kyoko MaesatoDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.
Hidekazu MoriyaDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.ORCID 0000-0002-3252-2976
Sumi HidakaDepartment of Kidney Disease & Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.ORCID 0000-0002-1576-0868

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asymmetric dimethylargininechronic kidney diseasecoronary artery calcificationprogressionrisk factor

Identifiers

PMID40004582
PMCPMC11856865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.